EASTMAN KODAK CO
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
KODK$8.29+3.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Cash Flows (Unaudited)
| Six Months Ended | ||
|---|---|---|
| June 30, | ||
| (in millions) | 2026 | 2025 |
| Cash flows from operating activities: | ||
| Net earnings (loss) | $1 | $(33) |
| Adjustments to reconcile to net cash used in operating activities: | ||
| Depreciation and amortization | 13 | 14 |
| Pension and postretirement income | (1) | (28) |
| Change in fair value of preferred stock embedded derivative | 10 | — |
| Change in fair value of KRIP reversion investment assets | (6) | — |
| Asset impairment | — | 17 |
| Paid-in-kind interest expense | — | 21 |
| Non-cash changes in workers' compensation and employee benefit reserves | (1) | 1 |
| Stock based compensation | 14 | 3 |
| Net gain from sale of assets | (1) | — |
| Loss on early extinguishment of debt | 2 | — |
| Provision for deferred income taxes | 1 | 1 |
| Increase in trade receivables | (6) | (3) |
| (Increase) decrease in miscellaneous receivables | (6) | 3 |
| Increase in inventories | (37) | (13) |
| Increase (decrease) in trade payables | 4 | (8) |
| Decrease in liabilities excluding borrowings and trade payables | (23) | (21) |
| Other items, net | 11 | 16 |
| Total adjustments | (26) | 3 |
| Net cash used in operating activities | (25) | (30) |
| Cash flows from investing activities: | ||
| Additions to properties | (11) | (24) |
| Proceeds from sale of preferred equity investment | 2 | — |
| Proceeds from redemption of KRIP reversion investments | 87 | — |
| Net proceeds from the sale of assets | — | 5 |
| Net cash provided by (used in) investing activities | 78 | (19) |
| Cash flows from financing activities: | ||
| Repayment of Amended and Restated Term Loan Agreement | (101) | — |
| Preferred stock cash dividend payments | (4) | (2) |
| Treasury stock purchases | (2) | (2) |
| Proceeds from exercise of employee stock options | 1 | — |
| Net cash used in financing activities | (106) | (4) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (1) | 5 |
| Net decrease in cash, cash equivalents and restricted cash | (54) | (48) |
| Cash, cash equivalents and restricted cash, beginning of period | 442 | 301 |
| Cash, cash equivalents and restricted cash, end of period | $388 | $253 |
| Non-cash Financing Item: | ||
| Series B preferred stock embedded derivative liability at issuance | $30 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.